Establishing Outcomes of Once-Daily ICS/LABA/LAMA Plus PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations (SUNDIAL-COPD)
Latest Information Update: 06 Mar 2024
At a glance
- Drugs Fluticasone furoate/umeclidinium/vilanterol (Primary) ; Fluticasone furoate/umeclidinium/vilanterol (Primary) ; Bronchodilators
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms SUNDIAL-COPD
- 01 Apr 2022 New trial record